StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –

Novartis Total Straight Bonds Carrying Value across 3 Issuing by Year

Total Straight Bonds Carrying Value across 3 Issuing Entities ($M)

Novartis Total Straight Bonds Carrying Value across 3 Issuing: $28,429M in FY2025, up 15.4% from a year earlier.

Latest, FY2025
28,429
Period ended Dec 31, 2025
Change on a year earlier
+15.4%
24,635 in FY2024
History
3 years
Since FY2023
Sources
2
Documents cited below

Where the FY2025 figure comes from

Source: Novartis Form 20-F (0001114448-26-000004) ↗

Full breakdown of the 24 continuously outstanding bond issues (FY2024–FY2025) of Novartis Capital Corporation (US), Novartis Finance S.A. (Luxembourg), and Novartis AG (Switzerland)

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Straight Bonds Carrying Value across 3 Issuing Entities ($M)Year on yearSource
FY2025Dec 31, 202528,429+15.4%Novartis Form 20-F (0001114448-26-000004) ↗
FY2024Dec 31, 202424,635+19.7%Novartis Form 20-F (0001114448-26-000004) ↗
FY2023Dec 31, 202320,585–Novartis Form 20-F (0001370368-25-000004) ↗

Breakdown

What makes up total Straight Bonds Carrying Value across 3 Issuing

Cite this data

StockData. (2026). Novartis Total Straight Bonds Carrying Value across 3 Issuing ($M), annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/sub-bonds-total-carrying

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.